Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 1

Conditions

Cardiotoxicity 14Breast Neoplasms 11Lymphoma, Non-Hodgkin 5Neoplasms 4Lymphoma 4Heart Failure 4Prostatic Neoplasms 2Multiple Myeloma 2Lymphoma, Follicular 2Lymphoma, B-Cell 2Leukemia 2Heart Diseases 2Cardiovascular Diseases 2Burkitt Lymphoma 2Ventricular Dysfunction, Left 1Ventricular Dysfunction 1Thoracic Neoplasms 1Small Cell Lung Carcinoma 1Radiation Injuries 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Philadelphia Chromosome 1Peritoneal Neoplasms 1Obesity 1Neoplasm, Residual 1Myeloproliferative Disorders 1Myelodysplastic Syndromes 1Metastatic Solid Tumors 1Metabolic Syndrome 1Mesothelioma 1Memory Disorders 1

Interventions

Cyclophosphamide 2varlilumab 1Vincristine 1Tomography, X-Ray Computed 1Rituximab 1Prednisone 1Nivolumab 1Interferons 1Immunoglobulin G 1Etoposide 1Echocardiography 1EPOCH protocol 1Doxorubicin 1Disulfides 1Caves 1Bendamustine Hydrochloride 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Lymphomatoid Granulomatosis × Echocardiography × Clear all
NCT00001379 2025-06-19

Treatment and Natural History Study of Lymphomatoid Granulomatosis

National Institutes of Health Clinical Center (CC)

Phase 2 Completed
94 enrolled 20 charts
Lymphoid

Lymphoma, Lymphoma, Non-Hodgkin, Lymphomatoid Granulomatosis, Lymphoproliferative Disorders, Epstein-Barr Virus Infections

Data powered by HemOnc (CC BY 4.0) Colophon âš¡